Skip to main content
SpringerLink
Log in

Tamoxifen eliminates estrogen’s neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

The capacity for 17-a and 17-B estradiol to modulate MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system and potential antagonism of this modulation by the anti-estrogen, tamoxifen, were evaluated. Treatment of retired breeder ovariect-omized C57/BI mice with17-B estradiol diminished the amount of striatal dopamine reduction resulting from MPTP treatment with striatal dopamine concentrations of these17-B estradiol treated mice failing to differ significantly from vehicle treated controls. A combined administration of17-B estradiol with tamoxifen abolished this neuroprotective effect of estrogen as striatal dopamine concentrations of this group were significantly lower than vehicle treated controls. Results to17-a estradiol were less effective since striatal dopamine concentrations of these mice following MPTP treatment were significantly decreased as compared with vehicle controls. In contrast to the nigrostriatal dopaminergic system, no statistically significant effects of these treatments were observed upon olfactory bulb dopamine concentrations. Taken together, these results show that17-B, but not an equivalent concentration of17-a, estradiol was effective in decreasing striatal dopamine neurotoxicity to MPTP. This effect of 17-Bestradiol was abolished by tamoxifen. These data have important implications regarding the mechanisms of estrogen-tamoxifen interactions within the nigrostriatal dopaminergic system as well as for clinical applications of tamoxifen within pre-menopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ali, S. F. and Freyaldenhoven, T.E. (1999) MPTP — A model of Parkinson’s disease. In Bondy, S. C. (Ed): Chemicals and Neurodegenerative Disease (Scottsdale, AZ; Prominent Press), pp. 162–188.

    Google Scholar 

  • Behl, C. and Holsboer, F. (1999) The female sex hormone oestrogen as a neuroprotectant. TiPS20, 441–444.

    PubMed  CAS  Google Scholar 

  • Behl, C, Skutella, T., Lezoualc’h, F., Post, A., Widmann, M., Newton, C. J. and Holsboer, F. (1997) Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Molec. Pharmacol.51, 535–541.

    CAS  Google Scholar 

  • Brooks, W. J., Jarvis, M. F. and Wagner, G. C. (1998) Influence of sex, age and strain of MPTF-induced neurotoxicity. Res. Comm. Subst. Abuse10, 181–184.

    Google Scholar 

  • Date, I., Felten. D. L. and Felten, S. Y. (1990) Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. Brain Res.519, 266–276.

    Article  PubMed  CAS  Google Scholar 

  • Dicko, A., Morissette, M., Ben Ameur, S.; Pezolet, M. and Di Paolo, T. (1999) Effect of estradiol and tamoxifen on brain membranes: Investigation by infrared and fluorescence spectroscopy. Brain Res. Bull.49, 401–405.

    Article  PubMed  CAS  Google Scholar 

  • Dluzen, D. E. (1996) Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system in male C57/BI mice. Brain Res.715, 113–118.

    Article  PubMed  CAS  Google Scholar 

  • Dluzen, D. E. (1997) Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res.767, 340–344.

    Article  PubMed  CAS  Google Scholar 

  • Dluzen, D. E. (2000) Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J. Neurocytol.29, 387–399.

    Article  PubMed  CAS  Google Scholar 

  • Dluzen, D. E., Disshon, K. A. and McDermott, J. L. (1998) Estrogen as a modulator of striatal dopaminergic neurotoxicity. In Marwah, J. and Teitelbaum, H. (Eds) Recent Advances in Neurodegenerative Disorders (Scottsdale, AZ; Prominent Press), pp. 149–192.

    Google Scholar 

  • Dluzen, D. E. and McDermott, J. L. (2000a) Gender differences in the neurotoxicity of the nigrostriatal dopaminergic system: Implications for parkinson’s disease. J. Gender-Specific Med.3, 36–42.

    CAS  Google Scholar 

  • Dluzen, D. E. and McDermott, J. L. (2000b) Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system. Ann. NY Acad. Sci.914, 112–126.

    PubMed  CAS  Google Scholar 

  • Dluzen, D. E., McDermott, J. L. and Liu, B. (1996a) Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal concentrations and release. J. Neuro-chem.66, 658–666.

    CAS  Google Scholar 

  • Dluzen, D. E., McDermott, J. L. and Liu, B. (1996b) Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/BI mice. Neurotox. Teratol.18, 603–606.

    Article  CAS  Google Scholar 

  • Farhat, M. Y., Abi-Younes, S., Dingaan, B., Vargas, R. and Ramwell, P. W. (1996) Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J. Pharmacol. Exp. Ther.276, 652–657.

    PubMed  CAS  Google Scholar 

  • Freyaldenhoven, T. E., Cadet, J. L. and Ali, S. F. (1996) The dopamine depleting effect of l-methyl-4-phe-nyl-l,2,3,6-tetrahydropyridine in CD-I mice are gender dependent. Brain Res.735, 232–238.

    Article  PubMed  CAS  Google Scholar 

  • Gao, X. and Dluzen, D. E. (2000) Tamoxifen abolishes estrogen’s neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Neuroscience — submitted.

  • Grandbois, M., Morissette, M., Callier, S. and Di Paolo, T. (2000) Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice. NeuroRe-port11, 343–346.

    Article  CAS  Google Scholar 

  • Grandbois, M., Tanguay, B. and Di Paolo, T. (1999) Estradiol and dehydroepiandrosterone but not dihydrotestoster-one protect against MPTP-induced dopamine depletion in mice. Soc. Neurosci.25, 1595 (Abstract).

    Google Scholar 

  • Green, P. S., Bishop, J. and Simpkins, J. W. (1997) 17-estra-diol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci.15, 511–515.

    Google Scholar 

  • Gupta, M., Gupta, B. K., Thomas, R., Bruemmer, V., Sladek Jr., J. R. and Felten, D. L. (1986) Aged mice are more sensitive to l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine treatment than young adults. Neurosci. Lett.70, 326–331.

    Article  PubMed  CAS  Google Scholar 

  • Jordan, V. G. and Morrow, M. (1999) Tamoxifen, raloxifene and the prevention of breast cancer. Endocrin. Rev.20, 253–278.

    Article  CAS  Google Scholar 

  • McDermott, J. L., Anderson, L.I. and Dluzen, D. E. (1997) Interactive effects of tamoxifen and estrogen upon the nigrostriatal dopaminergic system. Neuroendocrinology66, 181–187.

    Article  PubMed  CAS  Google Scholar 

  • McDermott, J. L., Anderson, L.I. and Dluzen, D. E. (1999) Interactive effects of tamoxifen and oestrogen upon the nigrostriatal dopaminergic system: Long-term treatments. J. Neuroendocrin.11, 801–803.

    Article  CAS  Google Scholar 

  • McDermott, J. L., Anderson, L.I. and Dluzen, D. E. (1998) Tamoxifen alters dopamine output through direct actions upon superfused corpus striatal tissue fragments. Neurochem Int.32, 299–307.

    Article  PubMed  CAS  Google Scholar 

  • McEwen, B. S. and Alves, S. E. (1999) Estrogen actions in the central nervous system. Endocrin. Rev.20, 279–307.

    Article  CAS  Google Scholar 

  • Mermelstein, P. G., Becker, J. B. and Surmeier, D. J. (1996) Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci.16, 595–604.

    PubMed  CAS  Google Scholar 

  • Miller, D. B. (1998) Endocrine disruption: estrogen androgen and the nervous system. In Tilson, H. A. and Harry, G. J. (Eds.) Neurotoxicology (Taylor & Francis), pp. 201-217.

  • Miller, D. B., Ali, S. F., O’Callaghan, J. P. and Laws, S. C. (1998) The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann. NY Acad. Sci.844, 153–165.

    Article  PubMed  CAS  Google Scholar 

  • Ramirez, V. D., Kim, K. and Dluzen, D. E. (1985) Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems:In vitro andin vivo studies. Rec. Prog. Horm. Res.41, 421–172.

    PubMed  CAS  Google Scholar 

  • Simerly, R. B., Chang, C, Muramatsu, M. and Swanson, L. W. (1990) Distribution of androgen and estrogen receptor mRNA containing cells in the rat brain: Anin situ hybridization study. J. Comp. Neurol.294, 76–95.

    Article  PubMed  CAS  Google Scholar 

  • Singer, C. A., Rogers, K. L., Strickland, T. M. and Dorsa, D. M. (1996) Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett.212, 13–16.

    Article  PubMed  CAS  Google Scholar 

  • Stephenson, J. (1999) Experts debate drugs for healthy women with breast cancer risk. J.A.M.A.282, 117–118.

    Article  PubMed  CAS  Google Scholar 

  • Van Hartesveldt, C. and Joyce, J. N. (1986) Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev.10, 1–14.

    Article  PubMed  Google Scholar 

  • Wagner, G. C, Tekirian, T. L. and Cheo, C. T. (1993) Sexual differences in sensitivity to methamphetamine toxicity. J. Neural Transm.93, 67–70.

    Article  CAS  Google Scholar 

  • Yu, Y-L. and Liao, P-C. (2000) Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J. Neural Transm.107, 419–427.

    Article  PubMed  CAS  Google Scholar 

  • Yu, Y-L. and Wagner, G. C. (1994) Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. J. Neural Transm. [P-D Sect]8, 215–221.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy Northeastern, Ohio Universities College of Medicine, Japan

    Dean E. Dluzen, Janet L. Mcdermott & Linda I. Anderson

  2. Department of Internal Medicine, Edwin Shaw Hospital, Japan

    Janet L. Mcdermott

Authors
  1. Dean E. Dluzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janet L. Mcdermott
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Linda I. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dean E. Dluzen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dluzen, D.E., Mcdermott, J.L. & Anderson, L.I. Tamoxifen eliminates estrogen’s neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system. neurotox res 3, 291–300 (2001). https://doi.org/10.1007/BF03033268

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033268

Keywords

Search

Navigation